Literature DB >> 6094225

Ascorbic acid inhibits the activity of polymorphonuclear leukocytes in inflamed ocular tissues.

R N Williams, C A Paterson, K E Eakins, P Bhattacherjee.   

Abstract

Myeloperoxidase (MPO) is present at high levels in polymorphonuclear leukocytes (PMNs) and has been used as a marker to quantify the accumulation of PMNs in inflamed tissues. MPO activity in inflamed ocular tissues was inhibited by aspirates of aqueous humor. This inhibition could be duplicated by the addition of ascorbic acid at concentrations equivalent to those present in the aliquots of aqueous humor. Similarly, aqueous humor and ascorbic acid inhibited MPO from isolated rabbit leukocytes. Therefore, ascorbic acid appears to inhibit the functional activity of the peroxidase in PMNs, thus preventing potential tissue damage by this enzyme when released during leukocyte degranulation in inflammation. Ascorbic acid might fulfill a role as an endogenous anti-inflammatory agent in the eye.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094225     DOI: 10.1016/0014-4835(84)90014-9

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  Ascorbic acid in the anterior chamber: can it be measured noninvasively?

Authors:  C K Chou; J T Penniston; R F Brubaker
Journal:  Trans Am Ophthalmol Soc       Date:  1986

2.  Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients.

Authors:  J van Rooij; S G Schwartzenberg; P G Mulder; S G Baarsma
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

3.  Retinal toxicity of intravitreal lazaroid (21-aminosteroid U75412E).

Authors:  S A Cruz; M Karaçorlu; G A Peyman
Journal:  Int Ophthalmol       Date:  1992-05       Impact factor: 2.031

Review 4.  Antioxidant delivery pathways in the anterior eye.

Authors:  Ankita Umapathy; Paul Donaldson; Julie Lim
Journal:  Biomed Res Int       Date:  2013-09-26       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.